Partnership

Start an enterprise licensing conversation with Apogee.

Briefings are scoped to your service line, panel, and clinical operations. We engage with health systems, longevity platforms, executive health programs, EHR-adjacent partners, and clinical innovation and strategic licensing teams.

What to expect from a first conversation.

A grounded 45-minute working session — not a sales demo — focused on what MPS would actually look like inside your service line.

01 · ScopeService line, panel, physiologic testing stack, EHR landscape
02 · PlatformWalkthrough of MPS capabilities against your specific clinical context
03 · WorkflowHow MPS plugs into clinical operations, clinician adoption, and EHR document flow
04 · DiligenceSecurity, data, and configuration review approach; BAA path; tenancy options
05 · PilotPilot structure, success criteria, and rollout cadence aligned to your program
06 · CommercialEnterprise licensing model and partnership structure

Request an enterprise briefing

Share a few details and we’ll route the conversation to the right Apogee partner lead within one business day.

Name Work email Organization Role Context (optional)

After submitting, you’ll see a brief confirmation from our secure form handler.

By submitting, you agree that Apogee may contact you about MPS partnership. No marketing list.

Diligence

Security & data review, by design.

Apogee expects enterprise diligence. Review packages are pre-assembled and shared with your security, privacy, and clinical-IT reviewers as part of every engagement — not after commercial terms.

Security posture

Encryption in transit and at rest. Role-based access, audit logging, institutional SSO. Dedicated tenancy and in-region hosting available.

HIPAA-aligned, BAA available

Apogee operates in alignment with HIPAA expectations and offers Business Associate Agreements under enterprise engagements. We do not claim HIPAA “certification” — none exists.

Clinical configuration review

Risk thresholds, phenotype definitions, and recommendation logic are documented and version-controlled — reviewable by your clinical leadership at every release.

Apogee Precision Technologies, Inc. is the developer of the patent-pending Metabolic Precision Suite (MPS). MPS is a clinical decision-support layer configured to fit institutional protocols. MPS is not a diagnostic device and is not FDA-cleared. Clinical decisions remain with the licensed clinician.